Weight loss drug is not taking easy way out

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...